BH
Buggana Hariharnath
About Buggana Hariharnath
Data last updated:
Buggana Hariharnath is a Nominee Director at Symbiotec Pharmalab Limited (since 2024), Director at Maiva Pharma Private Limited (since 2024) and Nominee Director at Accumax Lab Devices Private Limited (since 2024), and holds 7 more current directorships. The companies operate in Pharma, Healthcare and Life Sciences. The 7 current companies with reported revenue have a combined latest revenue of ₹1,600 Cr; the largest is Symbiotec Pharmalab Limited at ₹756 Cr (FY 2025). Earlier, Buggana Hariharnath was a Director at Strides Consumer Private Limited (2018–2024) and Director at Gland Pharma Ltd (2007–2014) and 9 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Symbiotec Pharmalab Limited U24232MP2002PLC015293 | Nominee Director | 16 Sep 2024 | 2002 | ₹756 Cr (FY 2025) | Active |
 Maiva Pharma Private Limited U24231KA1993PTC013976 | Director | 13 Sep 2024 | 1993 | ₹399 Cr (FY 2025) | Active |
 Accumax Lab Devices Private Limited U33110GJ2009PTC056957 | Nominee Director | 04 Sep 2024 | 2009 | ₹256 Cr (FY 2025) | Active |
 Aurigene Oncology Limited U24239KA2001PLC029391 | Director | 30 Mar 2015 | 2001 | ₹172 Cr (FY 2025) | Active |
| Designated Partner | 19 Oct 2020 | 2020 | ₹10.68 Cr (FY 2021) | Active | |
 Maiva Lifesciences Private Limited U24110TN2022PTC154153 | Director | 05 Sep 2024 | 2022 | ₹5.70 Cr (FY 2025) | Active |
| Knovea Pharmaceutical Private Limited U24110MP2020PTC050978 | Nominee Director | 16 Sep 2024 | 2020 | ₹62.7 Lakh (FY 2025) | Active |
| Rpg Active Pharma Limited U21001MH2025PLC464091 | Additional Director | 09 Sep 2026 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Strides Consumer Private Limited U24100MH2017PTC292022 | Director | 20 Dec 2018 | 2017 | ₹3.50 Cr (FY 2025) | Active |
 Gland Pharma Ltd L24239TG1978PLC002276 | Director | 22 Dec 2007 | 1978 | ₹6,747 Cr (FY 2026) | Active |
 Dr. Agarwal's Health Care Limited L85100TN2010PLC075403 | Director | 18 Jan 2011 | 2010 | ₹2,125 Cr (FY 2026) | Active |
| Suryateja Healthcare Private Limited U85100TG2014PTC093806 | Director | 01 Jun 2021 | 2014 | ₹14.87 Cr (FY 2025) | Active |
| Young President's Organisation Hyderabad Chapter U93000TG2007NPL055534 | Director | 06 Jul 2013 | 2007 | ₹4.52 Cr (FY 2026) | Active |
 Sahrudaya Health Care Private Limited U85100TG2011PTC072383 | Nominee Director | 13 Apr 2015 | 2011 | ₹1,837 Cr (FY 2025) | Active |
 Invascent Advisory Services India Private Limited U74140TG2006PTC050912 | Managing Director | 09 Sep 2006 | 2006 | ₹15.58 Cr (FY 2020) | Converted To Llp |
 Rajyalakshmi Healthcare Private Limited U85100TG2015PTC099232 | Director | 01 Jun 2021 | 2015 | ₹157 Cr (FY 2024) | Amalgamated |
| Total Prosthetics & Orthotics India Private Limited U33110HR2011PTC044590 | Nominee Director | 09 Jan 2015 | 2011 | ₹168 Cr (FY 2022) | Under Liquidation |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Buggana Hariharnath
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Buggana Hariharnath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Buggana Hariharnath
Buggana Hariharnath currently holds 10 directorships: Symbiotec Pharmalab Limited (Nominee Director, since 16 Sep 2024, revenue ₹756 Cr (FY 2025)); Maiva Pharma Private Limited (Director, since 13 Sep 2024, revenue ₹399 Cr (FY 2025)); Accumax Lab Devices Private Limited (Nominee Director, since 04 Sep 2024, revenue ₹256 Cr (FY 2025)); Aurigene Oncology Limited (Director, since 30 Mar 2015, revenue ₹172 Cr (FY 2025)); Invascent Advisory Services India Llp (Designated Partner, since 19 Oct 2020, revenue ₹10.68 Cr (FY 2021)); and 5 more.
Buggana Hariharnath was first appointed on 09 Sep 2006 as Managing Director at Invascent Advisory Services India Private Limited. The most recent appointment on record is 09 Sep 2026 at Rpg Active Pharma Limited.
The 7 current companies of Buggana Hariharnath that report revenue have a combined latest revenue of ₹1,600 Cr: Symbiotec Pharmalab Limited ₹756 Cr (FY 2025); Maiva Pharma Private Limited ₹399 Cr (FY 2025); Accumax Lab Devices Private Limited ₹256 Cr (FY 2025); Aurigene Oncology Limited ₹172 Cr (FY 2025); Invascent Advisory Services India Llp ₹10.68 Cr (FY 2021); and 2 more.
Buggana Hariharnath held 11 earlier board appointments: Strides Consumer Private Limited (Director, 20 Dec 2018 to 31 Aug 2024); Gland Pharma Ltd (Director, 22 Dec 2007 to 17 Jun 2014); Dr. Agarwal's Health Care Limited (Director, 18 Jan 2011 to 11 Jan 2016); Suryateja Healthcare Private Limited (Director, 01 Jun 2021 to 08 Jul 2021); Young President's Organisation Hyderabad Chapter (Director, 06 Jul 2013 to 02 Jul 2016); and 6 more.
The current boards of Buggana Hariharnath's companies include Anil Satwani (Symbiotec Pharmalab Limited), Dhananjay Narendra Mungale (Symbiotec Pharmalab Limited), Pramod Kasat (Symbiotec Pharmalab Limited), Pratik Patel (Symbiotec Pharmalab Limited), Raghavender Ramachandran (Symbiotec Pharmalab Limited), Rohit Brijmohan Mantri (Symbiotec Pharmalab Limited), among others.